↓ Skip to main content

microRNA: Medical Evidence

Overview of attention for book
Attention for Chapter 3: microRNA and Pain.
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
microRNA and Pain.
Chapter number 3
Book title
microRNA: Medical Evidence
Published in
Advances in experimental medicine and biology, January 2015
DOI 10.1007/978-3-319-22671-2_3
Pubmed ID
Book ISBNs
978-3-31-922670-5, 978-3-31-922671-2
Authors

Sakai, Atsushi, Suzuki, Hidenori, Atsushi Sakai, Hidenori Suzuki

Editors

Gaetano Santulli

Abstract

Pain is an important protective system that alerts organisms to actual or possible tissue damage. However, a variety of pathologies can lead to chronic pain that is no longer beneficial. Lesions or diseases of the somatosensory nervous system cause intractable neuropathic pain that occasionally lasts even after the original pathology subsides. Chronic inflammatory diseases like arthritis are also associated with severe pain. Because conventional analgesics such as non-steroidal anti-inflammatory drugs and opioids have limited efficacy and/or severe adverse events associated with long-term use, chronic pain remains a major problem in clinical practice. Recently, causal roles of microRNAs in chronic pain and their therapeutic potential have been emerging. microRNA expressions are altered not only at the primary origin of pain, but also along the somatosensory pathways. Notably, microRNA expressions are differentially affected depending on the causes of chronic pain. This chapter summarizes current insights into the roles of microRNAs in pain based on the underlying pathologies.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 18%
Student > Doctoral Student 3 14%
Student > Ph. D. Student 3 14%
Other 1 5%
Student > Bachelor 1 5%
Other 2 9%
Unknown 8 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 18%
Medicine and Dentistry 4 18%
Nursing and Health Professions 2 9%
Agricultural and Biological Sciences 2 9%
Business, Management and Accounting 1 5%
Other 0 0%
Unknown 9 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2015.
All research outputs
#23,391,126
of 26,017,215 outputs
Outputs from Advances in experimental medicine and biology
#4,336
of 5,312 outputs
Outputs of similar age
#313,483
of 365,650 outputs
Outputs of similar age from Advances in experimental medicine and biology
#197
of 276 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,312 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,650 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.